Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Healthcare (Basel) ; 10(7)2022 Jun 23.
Artículo en Inglés | MEDLINE | ID: mdl-35885704

RESUMEN

Background: Providing holistic care to kidney patients is important; however, without full consideration of the perspectives of people living with a kidney transplant, the provision of truly 'holistic healthcare' cannot be possible. It is imperative to understand patient experiences by including kidney patients in key strategies and future renal service planning. Ignoring these important patient views means that there is a significant risk of inappropriate renal service provision and lack of adequate support, impacting overall health. The aim of this study was to develop an in-depth understanding of the lived experiences of kidney transplant recipients. Methods: A total of 23 participants were recruited between two regional nephrology units within the United Kingdom via clinical gatekeepers. In-depth interviews were undertaken. Interviews were digitally recorded, transcribed verbatim, and subjected to interpretative phenomenological analysis. Results: Two themes emerged: "managing ongoing fears of dialysis, distress, and COVID-19" and "dealing with difficult conversations". Conclusions: Renal healthcare professionals need to understand more than the biological impact of receiving a kidney transplant. Understanding the holistic and multidomain experiences that these participants experience will help healthcare professionals to recognize the needs of this group and ensure more responsive psychosocial care.

2.
BMC Nephrol ; 22(1): 301, 2021 09 07.
Artículo en Inglés | MEDLINE | ID: mdl-34493246

RESUMEN

BACKGROUND: Globally, renal healthcare practitioners provide intensive and protracted support to a highly complex multi-morbid patient population however knowledge about the impact of COVID-19 on these practitioners is extremely limited. OBJECTIVE: This study aimed to explore the experiences of COVID-19 with renal healthcare practitioners during the first global lockdown between June 2020 and September 2020. METHODS: A multi-methods approach was carried out including a quantitative survey and qualitative interviews. This was a multinational study of renal healthcare practitioners from 29 countries. Quantitative: A self-designed survey on COVID-19 experiences and standardised questionnaires (General Health Questionnaire-12; Maslach Burnout Inventory). Descriptive statistics were generated for numerical data. Qualitative: Online semi-structured interviews were conducted. Data was subjected to thematic analysis. Renal healthcare practitioners (n = 251) completed an online survey. Thirteen renal healthcare practitioners took part in semi-structured interviews (12 nurses and 1 dietician). RESULTS: The majority of participants surveyed were female (86.9 %; n = 218), nurses (86.9 %; n = 218) with an average 21.5 (SD = 11.1) years' experience since professional qualification, and 16.3 years (SD = 9.3) working in renal healthcare. Survey responses indicated a level of preparedness, training and satisfactory personal protective equipment during the pandemic however approximately 40.3 % experienced fear about attending work, and 49.8 % experienced mental health distress. The highest prevalence of burnout was emotional exhaustion (35.9 %). Three themes emerged from the qualitative analysis highlighting the holistic complexities in managing renal healthcare, a neglected specialist workforce, and the need for appropriate support at work during a pandemic. CONCLUSIONS: Results have highlighted the psychological impact, in terms of emotional exhaustion and mental health distress in our sample of renal healthcare practitioners. As the pandemic has continued, it is important to consider the long-term impact on an already stretched workforce including the risk of developing mental health disorders. Future research and interventions are required to understand and improve the provision of psychological support for specialist medical and nursing personnel.


Asunto(s)
COVID-19/epidemiología , Salud Global , Nefrología/estadística & datos numéricos , Pandemias , Adulto , Anciano , Agotamiento Profesional/epidemiología , Agotamiento Profesional/psicología , COVID-19/terapia , Competencia Clínica/estadística & datos numéricos , Miedo/psicología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermería en Nefrología/economía , Enfermería en Nefrología/estadística & datos numéricos , Personal de Enfermería en Hospital/psicología , Personal de Enfermería en Hospital/estadística & datos numéricos , Enfermedades Profesionales/epidemiología , Enfermedades Profesionales/psicología , Equipo de Protección Personal , Distrés Psicológico , Investigación Cualitativa , Recursos Humanos
3.
BMC Nephrol ; 22(1): 126, 2021 04 09.
Artículo en Inglés | MEDLINE | ID: mdl-33832458

RESUMEN

BACKGROUND: Haemodialysis (HD) patients tend to have higher levels of oxidative stress (OS), associated with increased morbidity and premature mortality, compared to the general population. Levels of malondialdehyde (MDA), a biomarker of OS, are reduced by the antioxidant properties of vitamin E (VE) but outcomes from randomised control trials of VE supplementation on MDA in HD patients have been inconsistent. METHODS: We undertook a systematic review and meta-analysis of adult HD patients from VE supplementation studies with measures of MDA. The following search criteria of MEDLINE and EMBASE were considered from inception to January 2020: 'dialysis' AND 'Vitamin E OR tocopherol' AND 'malondialdehyde OR MDA'. Two reviewers independently extracted study data and assessed risk of bias. Mean MDA levels and standard deviation were determined before and after VE supplementation. Standardised mean difference (SMD) and standard error were calculated as the within person difference and units of measure were not consistently recorded across all studies. The SMD were pooled using random effects meta-analysis. RESULTS: The SMD of MDA levels from 18 comparisons was significantly lower in HD patients following VE supplementation (- 1.55; confidence interval: - 2.17 to - 0.94, P < 0.00001). There were significant levels of heterogeneity between studies (I2 value = 91%; P < 0.00001) with evidence of potential publication bias toward smaller studies. CONCLUSIONS: Our findings support the use of VE to reduce the effects of OS in HD patients although high levels of heterogeneity and variation in the methodological approaches used by some studies highlight the need for further investigation.


Asunto(s)
Antioxidantes/uso terapéutico , Malondialdehído/sangre , Estrés Oxidativo/efectos de los fármacos , Diálisis Renal , Vitamina E/uso terapéutico , Antioxidantes/farmacología , Biomarcadores/sangre , Suplementos Dietéticos , Humanos , Diálisis Renal/efectos adversos , Vitamina E/farmacología
4.
Clin J Am Soc Nephrol ; 11(3): 423-30, 2016 Mar 07.
Artículo en Inglés | MEDLINE | ID: mdl-26712808

RESUMEN

BACKGROUND AND OBJECTIVES: In-center hemodialysis (HD) is often the default dialysis modality for older patients. Few centers use assisted peritoneal dialysis (PD), which enables treatment at home. This observational study compared quality of life (QoL) and physical function between older patients on assisted PD and HD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients on assisted PD who were >60 years old and on dialysis for >3 months were recruited and matched to patients on HD (needing hospital transport) by age, sex, diabetes, dialysis vintage, ethnicity, and index of deprivation. Frailty was assessed using the Clinical Frailty Scale. QoL assessments included Hospital Anxiety and Depression Scale (HADS), Short Form-12, Palliative Outcomes Symptom Scale (renal), Illness Intrusiveness Rating Scale, and Renal Treatment Satisfaction Questionnaire (RTSQ). Physical function was evaluated by Barthel Score and timed up and go test. RESULTS: In total, 251 patients (129 PD and 122 HD) were recruited. In unadjusted analysis, patients on assisted PD had a higher prevalence of possible depression (HADS>8; PD=38.8%; HD=23.8%; P=0.05) and higher HADS depression score (median: PD=6; HD=5; P=0.05) but higher RTSQ scores (median: PD=55; HD=51; P<0.01). In a generalized linear regression model adjusting for age, sex, comorbidity, dialysis vintage, and frailty, assisted PD continued to be associated with higher RTSQ scores (P=0.04) but not with other QoL measures. CONCLUSIONS: There are no differences in measures of QoL and physical function between older patients on assisted PD and comparable patients on HD, except for treatment satisfaction, which is higher in patients on PD. Assisted PD should be considered as an alternative to HD for older patients, allowing them to make their preferred choices.


Asunto(s)
Estado de Salud , Enfermedades Renales/terapia , Diálisis Peritoneal , Calidad de Vida , Factores de Edad , Anciano , Anciano de 80 o más Años , Distribución de Chi-Cuadrado , Comorbilidad , Estudios Transversales , Depresión/diagnóstico , Depresión/epidemiología , Depresión/psicología , Inglaterra/epidemiología , Femenino , Anciano Frágil , Evaluación Geriátrica/métodos , Humanos , Enfermedades Renales/diagnóstico , Enfermedades Renales/epidemiología , Enfermedades Renales/psicología , Modelos Lineales , Modelos Logísticos , Masculino , Persona de Mediana Edad , Irlanda del Norte/epidemiología , Satisfacción del Paciente , Diálisis Peritoneal/efectos adversos , Diálisis Peritoneal/psicología , Prevalencia , Diálisis Renal/efectos adversos , Diálisis Renal/psicología , Factores de Riesgo , Encuestas y Cuestionarios , Factores de Tiempo , Resultado del Tratamiento
5.
J Vasc Access ; 16(6): 439-45, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26109536

RESUMEN

BACKGROUND: The elderly form an expanding proportion of patients with chronic kidney disease and end-stage renal disease worldwide. The increased physiological frailty and functional morbidity associated with the aging process pose unique challenges when planning optimal management of an older patient needing renal replacement therapy (RRT). AIMS: This position paper discusses current evidence regarding the optimal management of end-stage renal disease in the elderly with an emphasis on hemodialysis since it is the most common modality used in older patients. Further research is needed to define relevant patient-reported outcome measures for end-stage renal disease including functional assessments and psychological impacts of various forms of RRT. For those older patients who have opted for dialysis treatment, it is important to study the strategies that encourage greater uptake of home-based dialysis therapies and optimal vascular access. CONCLUSIONS: The management of advanced chronic kidney disease in the elderly can be challenging but also extremely rewarding. The key issue is adopting a patient-focused and individualized approach that seeks to achieve the best outcomes based on a comprehensive holistic assessment of what is important to the patient.


Asunto(s)
Fallo Renal Crónico/terapia , Planificación de Atención al Paciente/normas , Atención Dirigida al Paciente/normas , Indicadores de Calidad de la Atención de Salud/normas , Diálisis Renal/normas , Factores de Edad , Anciano , Medicina Basada en la Evidencia/normas , Evaluación Geriátrica , Humanos , Fallo Renal Crónico/diagnóstico , Fallo Renal Crónico/psicología , Selección de Paciente , Atención Dirigida al Paciente/métodos , Calidad de Vida , Diálisis Renal/efectos adversos , Diálisis Renal/métodos , Factores de Riesgo , Resultado del Tratamiento , Reino Unido
6.
J Ren Care ; 41(1): 43-52, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25410622

RESUMEN

AIM: To review end-of-life care provided by renal healthcare professionals to hospital in-patients with chronic kidney disease, and their carers, over a 12-month period in Northern Ireland. METHODS: Retrospective review of 100 patients. RESULTS: Mean age at death was 72 years (19-95) and 56% were male. Eighty three percent of patients had a 'Not For Attempted Resuscitation' order during their last admission and this was implemented in 42%. Less than 20% of all patients died in a hospital ward. No patients had an advanced care plan, although 42% had commenced the Liverpool Care Pathway for the Dying Patient. Patients suffered excessive end-of-life symptoms. In addition, there was limited documentation of carer involvement and carer needs were not formally assessed. CONCLUSION: End-of-life care for patients with advanced chronic renal disease can be enhanced. There is significant variation in the recording of discussions regarding impending death and little preparation. There is poor recording of the patients' wishes regarding death. Those with declining functional status, including those frequently admitted to hospital require holistic assessment regarding end-of-life needs. More effective communication between the patient, family and multi-professional team is required for patients who are dying and those caring for them.


Asunto(s)
Hospitalización , Fallo Renal Crónico/enfermería , Cuidado Terminal/normas , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Conductas Relacionadas con la Salud , Humanos , Fallo Renal Crónico/mortalidad , Pruebas de Función Renal/enfermería , Masculino , Persona de Mediana Edad , Irlanda del Norte , Modelos de Riesgos Proporcionales , Órdenes de Resucitación , Estudios Retrospectivos , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA